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A B S T R A C T   
The general population is continuously exposed to phthalates via various consumer products. Epidemiological 
research relating phthalate exposure to thyroid function during non-developmental periods is limited. This study 
aimed to investigate the associations between specific serum phthalate metabolites and indicators of thyroid 
function in adults. We measured 10 serum phthalate metabolites and thyroid hormones – total triiodothyronine 
(TT3), free thyroxine (FT4) and thyroid stimulating hormone (TSH) – in a subsample of 207 adults from the 
GraMo cohort. This subsample was made up of men and women (in equal proportions) of middle age (49 ± 17 
years) and from Southern Spain (province of Granada). Data on age, sex, body mass index, residence area, to-
bacco use, alcohol consumption and attained education were obtained from a questionnaire. Phthalate metab-
olites were log-transformed and categorized into tertiles. Cross-sectional associations of each metabolite with 
thyroid hormones were analyzed using multivariable-adjusted linear regression models. The mixture effect of 
metabolite phthalates was assessed using weighted quantile sum regression. After multivariable-adjustment, the 
following phthalate metabolites were significantly associated with TT3 in a dose-response manner: MMP (β =
0.90: 95% confidence interval 0.68,1.12), MEP (β = 0.67: 0.44, 0.90), MiBP (β = 0.49: 0.21, 0.77), MiDP (β =
0.27: 0.03, 0.52), MBzP (β = 0.51: 0.28, 0.73), MEHP (β = − 0.59: − 0.82, − 0.35) and MiNP (β = -0.43: − 0.71, 
− 0.14), when comparing highest vs. lowest exposed. The sum of all metabolites was also linked to FT4 levels. No 
significant associations were observed for TSH except for MiNP. Although phthalate metabolites with different 
molecular weight showed opposite associations, overall metabolite concentrations seem to associate with 
increased TT3 and FT4 serum levels. The cross-sectional nature of this analysis limits causal inference.   
1. Introduction 
Phthalates, diesters of phthalic acids, are extensively used and can be 
found in numerous commercial products, including food packaging, 
building materials, furniture, interior and exterior of vehicles, children’s 
toys, medical devices, perfumes, air fresheners, cleaning products, 
clothing, pharmaceuticals (Hauser et al., 2004) and personal care 
product (Romero-Franco et al., 2011) among others supplies (Abadin 
et al., 2007; Heudorf et al., 2007). Phthalates are not chemically bound 
to the end products, being easily transferred to indoor dust, air, food, 
and water (Guo et al., 2012). Therefore, phthalates are widely distrib-
uted in the ecosystem and are frequently detected in general population 
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worldwide (Wang et al., 2019). Phthalates have a short half-life in 
human bodies (less than 24 h), since they are rapidly metabolized into 
monoesters of phthalates (Silva et al., 2007; Johns et al., 2015a), which 
is supposed to be the toxic form (Kavlock et al., 2002). 
Previous research has suggested that the diet, particularly fatty food 
(e.g., dairy, fish, oils), may contribute importantly to total phthalate 
exposure followed by indoor air and household dust (Petersen and 
Breindahl, 2000; Butte and Heinzow, 2002; Martinez et al., 2018; 
Wormuth et al., 2006). Biomarker measurements in biological fluids are 
an aggregate of all external exposure pathways and indicators of internal 
dose. Specifically, phthalate metabolites are suggested as indicators of 
the biologically effective dose of phthalate exposures. The measurement 
of phthalate monoester metabolites in urine has been the most common 
in epidemiology studies with some advantages over the measurement in 
blood, principally because of the higher concentrations of the metabo-
lites and reduced potential for contamination by the parent diester 
phthalate and subsequent formation of metabolites by enzymes present 
in blood (Centers for Disease Control and Prevention, 2009). However, 
studies conducted in general population have reported from moderate to 
strong correlations between urine and serum concentrations for phtha-
late metabolites and both biological matrices can be used as valid in-
dicators for human phthalate exposure (Frederiksen et al., 2010; Hines 
et al., 2009; Hogberg et al., 2008; Kato et al., 2004). 
Phthalates have long been an object of concern because of their 
potential effects on human health, especially in the reproductive system 
(19). Phthalates have also elicited thyroid hormone disrupting potential, 
through interference of their synthesis, transport, and metabolism (Zhai 
et al., 2014; Liu et al., 2015), including interference with thyroid hor-
mone, binding proteins and with the function of the 
hypothalamic-pituitary-thyroid (HPT) axis (Boas et al., 2012; Ye et al., 
2017). 
Most of the epidemiological studies assessing the potential associa-
tion between phthalate exposure and thyroid function have been con-
ducted in sensitive subpopulation groups, like pregnant women or 
infants and children, and have displayed conflicting results (Kim et al., 
2019). Among the limited studies conducted in adults, the metabolites 
associated, and the direction of association have differed (Wang et al., 
2018; Przybyla et al., 2018; Park et al., 2017; Meeker and Ferguson, 
2011; Meeker et al., 2007; Huang et al., 2017). The purpose of this work 
was, therefore, to gain more knowledge about the potential interference 
of phthalate exposure on thyroid hormones. To this end, we investigated 
the associations between several phthalate metabolites in serum and 
biomarkers of thyroid function in a sample of middle aged adults from 
Southern Spain. 
2. Material and methods 
2.1. Design and study population 
This research work is part of a larger, ongoing prospective study 
(GraMo cohort) that aims to investigate the role of various environ-
mental exposures, including persistent organic pollutants (Barrios-Ro-
dríguez et al., 2021; Mustieles et al., 2017), non-persistent chemicals 
(Artacho-Cordon et al., 2019), and metallic/metalloid elements (Salce-
do-Bellido et al., 2021; Freire et al., 2020), on the development of 
chronic health conditions. The study design, recruitment and biological 
sample collection have been extensively described elsewhere (Arrebola 
et al., 2010; Arrebola et al., 2009; Echeverria et al., 2019; Rodri-
guez-Perez et al., 2018). 
Briefly, the cohort was recruited in 2003–2004 in two public hos-
pitals in the province of Granada (Southern Spain), the San Cecilio 
University Hospital in Granada city (240,000 inhabitants, urban area) 
and Santa Ana Hospital in the town of Motril (50,000 habitants, semi- 
rural area). Participants were recruited from patients undergoing 
routine non-cancer-related surgery (hernias (41%), gallbladder disease 
(20%), varicose veins (11%), and other conditions (28%)). Eligible 
participants had to meet the following criteria: aged over 16 years, 
residence in the study areas for at least 10 years and absence of cancer 
and any hormonal disease related to hypothalamic axis. 
Data on socio-demographic characteristics, lifestyle, and health sta-
tus were gathered in face-to-face interviews conducted by trained 
personnel at the time of recruitment during the hospital stay. Body mass 
index (BMI) was expressed as weight/height squared (kg/m2). A 
participant was considered a smoker or alcohol consumer with any level 
of daily tobacco (≥1 cigarette/day) or weekly alcohol (≥1 drink/week) 
consumption. 
Out of 409 individuals who were contacted, 405 donated 12 h-fasting 
blood samples. Phthalate metabolites and hormonal biomarkers were 
measured in serum samples from 230 individuals. We also excluded 
those with missing data in any of the covariables involved in these an-
alyses (n = 23), leaving a final sample of 207 participants. No substantial 
sociodemographic differences were observed between the 207 partici-
pants included in the analysis and those that provided blood samples but 
had no phthalate exposure or clinical data (n = 197), except for the place 
of residence (urban or semi-rural) (Supplemental Table S1). 
All participants signed their informed consent to participation in the 
study, which was approved by the Ethics Committee of Granada (Comité 
de Ética de Investigación Clínica de Granada, 8/2016). 
2.2. Laboratory analysis 
2.2.1. Phthalate metabolite assessment 
The concentration of 32 phthalate metabolites from 15 different 
phthalate diesters (phthalates) were analyzed by isotope diluted online- 
TurboFlow- LC-MS/MS with preceding enzymatic de-conjugation. A 
detailed method description, validation, limits of detections (LOD), 
linear range, matrix effects, intra-day, and inter-day accuracy and pre-
cision have been previously published (Hart et al., 2018). For this study, 
samples were analyzed randomly and blinded for the technician in 5 
batches, each including calibration standards, about 40–45 unknown 
samples, three blanks, three serum pool controls, and three serum pool 
controls spiked with native phthalate metabolite standards at low or 
high level. The inter-day variation expressed as the relative standard 
deviation was <21% for all analytes spiked in serum at low level and 
<11% for all analytes spiked in serum at high level. 
Of the 32 phthalate metabolites measured in blood, we excluded 
those which levels were below the limit of detection (LOD) in more than 
75% of the samples. These 10 metabolites were as follows: mono-methyl 
phthalate (MMP), mono-ethyl phthalate (MEP), mono-iso-butyl phtha-
late (MiBP), mono-n-butyl phthalate (MnBP), mono-benzyl phthalate 
(MBzP), mono-(2-ethyl-hexyl) phthalate (MEHP), mono-(2-ethyl-5-car-
boxypentyl) phthalate (MECPP), mono-(2-carboxymethyl-hexyl) 
phthalate (MCMHP), mono-iso-nonyl phthalate (MiNP) and mono-iso- 
decyl phthalate (MiDP). Values < LOD, were substituted with LOD/ 
square root of 2 (Supplemental Tables S2 and S3). 
Phthalates can be classified between low molecular weight (LMW) 
(ester side-chain lengths, one to four carbons) and high molecular 
weight (HMW) (ester side-chain lengths, five or more carbons). LMW 
phthalates are mostly used in hygiene and personal care products, 
paints, adhesives, and medicine coatings, and corresponding metabo-
lites are: MMP, MEP, MiBP, MnBP and MBzP. Metabolites of LMW 
phthalates are MEHP, MECPP, MCMHP, MiNP and MiDP; are used pri-
marily in PVC polymers and plastisol applications, plastics, food pack-
aging, and food processing materials, vinyl toys and vinyl floor 
coverings, and building products (Danish EPA TDEPA, 2012; Wittassek 
et al., 2011) (Supplemental Table S2). 
2.3. Thyroid hormones assessment 
For the quantitative determination in serum of total triiodothyronine 
(TT3, nmol/L), free thyroxine (FT4, pmol/L) and thyroid stimulating 
hormone (TSH, mIU/L), in vitro immunological tests were performed on 
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the Cobas e-411 bioanalyzer (from Roche), based on electro-
chemiluminescence technology (ECLIA). 
We additionally identified those participants with TT3 y/o FT4 levels 
above the range considered normal (Education.endocrine.org., 2020; 
Ross et al., 2016). Hence, we considered as potential subclinical hy-
perthyroidism if any of TT3 > 3.08 nmol/L and/or FT4 >23.17 pmol/L. 
2.4. Statistical analysis 
Pairwise correlations between metabolites and hormones were 
assessed using the Spearman rank correlation coefficient (rho) and 
graphed. Concentrations of each phthalate were natural log-transformed 
and evaluated as continuous and as categorical, which relax the linearity 
assumption. MEP and MEHP, with <8% observations <LOD, were 
categorized into tertiles of the distribution by the usual procedure. 
MBzP, with 75% observations below the LOD, were dichotomized into 
<LOD and ≥ LOD. For the rest of the metabolites, the first category 
(reference) comprised those participants with undetectable phthalate 
levels (<LOD), and the rest of the participants were dichotomized and 
constituted the second and third categories. A sum of all phthalate 
metabolites was also calculated by summing the orders of each metab-
olite after categorization (i.e., the category number of each compound – 
1, 2 or 3 – was summed). 
Associations of phthalate concentrations with thyroid hormones 
(continuous) and with hyperthyroidism (dichotomous) were assessed 
cross-sectionally using multivariable linear and logistic regression ana-
lyses, generating beta coefficients (β) and odds ratios (OR), respectively, 
with corresponding 95% confidence intervals (CI). The β (95% CI) 
stratifying by sex were also estimated. 
Among covariates frequently reported in the existing bibliography, 
we based the selection of the covariates to be included as confounders to 
those that changed the estimation >5% or that were statistically sig-
nificant. Thus, model 1 was adjusted for age and sex and model 2 was 
further adjusted for BMI (continuous), residence area (urban/semi- 
rural), smoking habits (never, former, current), alcohol consumption 
(regular consumer/non-consumer) and attained education (incomplete 
primary, primary, higher education). Phthalates bind to estrogen re-
ceptors, which may be part of the mechanism of action on the disruption 
of thyroid hormones. On the other hand, estrogen levels (due to physi-
ological causes such as pregnancy, menstrual cycle, or other causes with 
iatrogenic/pathological origin) induce an increase in transporter glob-
ulin (TBG). Since 75–80% of thyroid hormone is bound to TBG, the in-
crease in TBG determines an increase in protein-bound thyroid hormone 
with a consequent decrease in free thyroid hormones. Therefore, we 
further adjusted the models for estrogen levels, but the results were 
unchanged. 
We further explored the association of phthalate metabolite con-
centrations with TT3 levels mutually adjusting each phthalate for the 
others, that is, including all phthalates in the same model. However, 
high correlation between chemicals might lead to result distortion 
Table 1 
Baseline main characteristics of the subsample adults from the GraMo cohort according to phthalate metabolite sum levels in tertiles (N = 207).  
Characteristics Phtalate metabolite suma 
1st terile (lowest levels) 2nd tertile 3rd tertile (highest levels) 
n 72 75 60 
Male [%, (n)] 51.4% (37) 44.0% (33) 51.7% (31) 
Age, yrs 48.9 (18.4) 49.9 (18.1) 48.3 (15.5) 
Body mass index, kg/m2 26.9 (5.3) 27.7 (6.1) 27.8 (4.9) 
Education level [%, (n)] 
Incomplete primary 25% (18) 30.7% (23) 26.7% (16) 
Primary 38.9% (28) 40% (30) 46.7% (28) 
Secondary or higher 36.1% (26) 29.3% (22) 26.7% (16) 
Residence (%) 
Urban (Granada) 68.1% (49) 20% (15) 13.3% (8) 
Semi-rural (Motril) 31.9% (23) 80% (60) 86.7% (52) 
Regular alcohol consumption (%) 45.8% (33) 50.7% (38) 65% (39) 
Tobacco use [%, (n)] 
Never smoked 45.8% (33) 42.7% (32) 36.7% (22) 
Former smokers 22.2% (16) 21.3% (16) 25% (15) 
Current smokers 31.9% (23) 36% (27) 38.3% (23) 
Estradiol blood levels, pg/ml 41.6 (48.8) 38.6 (56.1) 42.4 (57.6) 
Thyroid hormones levels 
Total triiodothyronine (TT3), nmol/L 2.52 (0.71) 2.23 (0.72) 2.69 (0.66) 
Free thyroxine (FT4), pmol/L 18.7 (6.8) 18.9 (7.8) 19.5 (8.2) 
Thyroid stimulating hormone (TSH), mIU/L 2.21 (1.95) 2.21 (1.69) 2.57 (1.45) 
Phtalate metabolite serum levels, ng/mL 
MMP 5.17 (7.63) 3.39 (7.91) 7.27 (5.86) 
MEP 11.8 (26.2) 15.7 (19.1) 44.3 (72.4) 
MiBP 1.13 (1.73) 4.98 (9.93) 19.83 (18.6) 
MnBP 0.96 (1.62) 5.07 (9.32) 20.93 (19.5) 
MBzP 0.2 (0.07) 0.27 (0.26) 0.72 (0.66) 
MEHP 1.98 4.09 (4.24) 3.19 (3.46) 
MECPP 0.82 (1.03) 1.26 (0.96) 2.44 (4.18) 
MCMHP 1.08 (1.45) 1.62 (1.89) 2.85 (4.91) 
MiNP 1.09 (1.12) 1.9 (1.31) 1.87 (1.25) 
MiDP 0.69 (0.49) 1.2 (0.96) 2.33 (2.14) 
Continuous variables are given as mean (standard deviation (SD)) and categorical variables are given as percentage (n). 
Abbreviations: MMP: Mono-methyl phthalate; MEP: Mono-ethyl phthalate; MiBP: Mono-iso-butyl phthalate; MnBP: Mono-n-butyl phthalate; MBzP: Mono-benzyl 
phthalate; MEHP: Mono-(2-ethyl-hexyl) phthalate; MECPP: Mono-(2-ethyl-5-carboxypentyl) phthalate; MCMHP: Mono-(2-carboxymethyl-hexyl) phthalate; MiNP: 
Mono-iso-nonyl phthalate; MiDP: Mono-iso-decyl phthalate. 
a The phthalate metabolite sum is the sum of orders of all metabolites (each metabolite was categorized in tertiles and the category number of each compound was 
summed). 
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(KAJAem, 2004). One strategy for evaluating environmental mixtures in 
observational studies is a focus on the concept of a mixture effect, where 
relevant environmental chemicals may be at exposures below an effect 
level, but joint action of the components may produce significant effects 
(Silva et al., 2002). Therefore, the potential mixture effect of the 
different phthalate metabolites on thyroid hormones was additionally 
assessed by means of weighted quantile sum (WQS) regression. WQS 
estimates a weighted index based on the combination of several expo-
sures, considering their individual associations with the outcome. The 
mixture effect of phthalate concentrations on thyroid hormone levels 
was then explored by entering the index as the independent variable in a 
single linear regression with the levels of each hormone as the depen-
dent variable and adjusting for the same covariates as the individual 
associations. The individual weight of each phthalate in the model was 
calculated in percentage. Considering that WQS regression needs to a 
priori set the expected direction of the association, we calculated two 
models for mixture effects (positive and negative) for each outcome. 
Associations of each WQS index with TT3 and FT4 levels were 
further studied by using multivariable-adjusted linear regression, 
adjusting for the same covariates included in the previous models. All 
WQS analyses were performed with tertile-scored pollutant concentra-
tions, using a training set defined as a 40% random sample of the dataset 
(n = 83), being the remaining 60% used for model validation (n = 124). 
The final weights were calculated using a total of 1000 bootstrap steps. 
The level of statistical significance was set at 0.05 and all tests were 2- 
tailed. The statistical software STATA/SE version 16.0 (Stata Corp LP, 
College Station, TX) was used to manage the database of the study and to 
perform statistical analyses. WQS analysis was performed by using R 
statistical computing environment v 3.4.0 (Team.RC, 2018), with gWQS 
package v2.0.1 (Stefano Renzetti et al., 2020). 
3. Results 
Table 1 summarizes the characteristics of the study population by 
tertiles of total phthalate concentrations sum. Participants with higher 
phthalate blood concentrations had lower attained education, were 
more likely to consume alcohol, to be current smokers and more likely to 
live in a semi-rural area (Motril). 
MEP was found at notably higher levels than the rest of the metab-
olites and MBzP concentrations were below the LOD in most of the 
subjects (Fig. 1). The concentrations were slightly lower in men than in 
women, except for MMP whose levels were the double in men than in 
women (Supplemental Table S2). Spearman correlation among phtha-
late metabolites were generally positive but lower than 0.5. Exceptions 
were for the pairs MiBP-MnBP and MECPP- MCMHP with stronger 
positive correlations (both rho: ~0.8) (Fig. 2 and Supplemental 
Figure S2). 
The mean (standard deviation (SD)) of TT3, FT4 and TSH levels was 
2.5 (0.7) nmol/L, 19.0 (7.6) pmol/L and 2.3 (1.7) mIU/L, respectively. 
Thus, the 31% of the participants (n = 64) had levels of TT3 or FT4 
above the reference values (i.e., 3.08 nmol/L for TT3 and 23.17 pmol/L 
for FT4) (Education.endocrine.org., 2020; Ross et al., 2016). 
After multivariable adjustment, all the LMW phthalate metabolites 
were individually associated with elevated TT3 blood levels in a dose- 
response manner, but no significant associations were observed for 
FT4 or TSH. Thus, when comparing the highest vs. the lowest category of 
phthalate metabolites levels, MMP, MEP, MiBP, MnBP and MBzP were 
associated with higher TT3 serum levels. By contrast, the HMW phtha-
late metabolites were inclined to be associated with lower TT3 and TSH 
levels, although only reaching statistical significance in the case of 
MEHP and TT3 and for MiNP and both TT3 and TSH. The exception was 
MiDP, which is an HMW phthalate, but still significantly associated with 
elevated TT3 levels. The overall sum of phthalate metabolites was 
associated with increased TT3 and FT4 blood levels: those in the highest 
category vs. those in the lowest category of the phthalate metabolite sum 
had, on average, 0.52 (95% CI 0.26, 0.78) nmol/L higher levels of TT3 
and 4.36 (1.47, 7.25) pmol/L higher levels of FT4 (Table 2, Fig. 3, and 
Supplemental Table S4). 
Although the associations of phthalate metabolites mutually 
adjusted for the others with TT3 levels decreased in magnitude, the 
trend remained the same (Supplemental Table S5). The mean variance 
inflation factor (VIF) for the overall resulting model was 3 (reaching 5 
Fig. 1. Box plot of blood phthalate metabolite median levels (ng/mL) of total study population and percentages of phthalate metabolite below limit of detection. 
Descriptive statistics (N = 207). 
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for some individual metabolites), therefore, certain impact of multi-
collinearity in this approach cannot be ruled out. After sex-stratification, 
the associations were fully consistent in terms of direction of the asso-
ciation – although slightly more pronounced in women than men – and 
statistical significance in both women and men; (Supplemental 
Table S5). 
When assessing the risk of being above the normal range in thyroid 
hormones, despite the of statistical power limitations, findings were 
consistent. In this approach, the strongest associations were found for 
MMP and MiDP; thus, those with highest levels of MMP and MiDP 
showed to have twice the risk of having a potential subclinical hyper-
thyroidism than those with undetectable levels (OR 2.41; 1.01, 5.73 and 
2.36; 1.01, 5.50; respectively) (Table 3). Adjustment for estradiol levels 
did not change the associations found. 
To account for the potential mixture effect of phthalate metabolites 
on thyroid hormone levels, we calculated a WQS index as a measure of 
the combined effect. In the multivariable linear regression model, the 
“positive” WQS index was positively and significantly associated with 
TT3 levels (β = 0.362; p value < 0.001), with MMP (32%), MnBP (23%), 
and MEP (21%) accounting for much of the index. In addition, the 
“negative” WQS index was negatively and significantly associated with 
TT3 levels (β = − 0.193; p value 0.002), being mainly represented by 
MEHP (38%), followed by MINP (17%) and MBZP (16%) (Fig. 4). While 
the “positive” WQS index was not significantly associated with FT4 (β =
0.142; p value 0.116), the “negative” WQS index was negatively and 
significantly associated with FT4 levels (β = − 0267, p value 0.007). 
4. Discussion 
To the best of our knowledge, this is the first study evidencing as-
sociations between circulating serum phthalate metabolites and levels of 
thyroid hormones in an adult population. While LMW phthalate me-
tabolites were individually associated with higher levels of TT3 in both 
sexes, HMW phthalate metabolites mostly associated with lower levels 
of serum TT3. The sum of all phthalate metabolites was associated with 
increases in TT3 and FT4 levels and this association was slightly more 
pronounced in women than men. No apparent associations between 
phthalate metabolites and TSH were found. Phthalate metabolites have 
similarities in their chemical structures and potential mechanisms of 
action and, therefore, there is increasing evidence of the potential ad-
ditive/synergic effect of the exposure to their mixtures (Baralic et al., 
2020). We addressed this issue by using two approaches. On the one 
hand, the sum of orders of all phthalate metabolites (LMW and HMW 
together) was associated with a significant increase in total TT3 levels, 
which indeed supports a potential additive mixture effect. However, this 
approach is based on chemical concentrations and does not take into 
account the possible distinct toxic potential that different phthalates 
may present. On the other hand, our analyses using WQS also supported 
a potential positive mixture effect of LMW phthalate metabolites on TT3 
levels, which was mainly accounted for by MMP, MnBP, and MEP in this 
order; as well as a potential negative mixture effect of HMW phthalate 
metabolites on TT3 levels, being mainly represented mostly by MEHP, 
followed by MINP and MCMHP. 
Phthalates have elicited endocrine-disrupting potential that can be 
mediated via interference with steroid hormones, including the sex 
Fig. 2. Spearman correlations between phthalate metabolite levels.  
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steroids, and thyroid hormone systems (Boas et al., 2012; Ghisari and 
Bonefeld-Jorgensen, 2009; Chebbi et al., 2020; Gore et al., 2015). DBP, 
MBP and DEHP have consistently exhibited an anti-androgenic as well as 
thyroid receptor (TR) antagonistic activity (Shi et al., 2011; Shen et al., 
2009). DIDP, DINP and DEHP also showed their thyroid hormone dis-
rupting potential by modulating sodium/iodide symporter (NIS)-me-
diated iodide uptake activity (Wenzel et al., 2005). DBP and MBP may 
also disrupt thyroid signaling by, e.g., inducing changes in the expres-
sion of thyroid hormone response genes or causing aberrant DNA 
methylation of TR (Shen et al., 2011). Further, DEHP reduces thyroid 
hormones via interacting with hormone synthesis-related proteins, 
deiodinases, transthyretin, receptors, and hepatic enzymes in rats (Liu 
et al., 2015; Dong et al., 2017; Erkekoglu et al., 2012). Likewise, acute 
exposure to MEHP alters whole-body contents of thyroid hormones in 
zebrafish embryos/larvae and changes the transcription of genes 
involved in the HPT axis, thus exerting thyroid endocrine toxicity (Zhai 
et al., 2014). 
However, while over the past two decades there has been a sub-
stantial research effort to evaluate biological effects of phthalates, many 
uncertainties remain. Given the diversity and complexity of the endo-
crine system, additional pathways besides direct agonists or antagonists 
for hormone receptors need to be explored (Baken et al., 2019), espe-
cially at lower doses and during longer periods, to better reflect human 
exposure. 
To our knowledge, a limited number of epidemiological studies 
looking at the potential association between phthalate exposure and 
Table 2 
Linear association between serum phthalate metabolite and thyroid hormone levels. Multivariable linear regression models (β and 95% CI per unit increase).  
Phthalate metabolites (ng/mL) c TT3 (nmol/L) FT4 (pmol/L) TSH (mIU/L) 
Model 1 Model 2 Model 1 Model 2 Model 1 Model 2 
β (95% CI) a β (95% CI) b β (95% CI) a β (95% CI) b β (95% CI) a β (95% CI) b 
MMP 0.24 (0.19, 0.29) 0.24 (0.18, 0.30) 0.62 (0.00, 1.24) 0.45 (− 0.25, 1.15) 0.13 (− 0.01, 0.27) 0.11 (− 0.05, 0.28) 
MEP 0.13 (0.07, 0.19) 0.17 (0.11, 0.23) − 0.13 (− 0.79, 0.54) 0.20 (− 0.48, 0.88) 0.18 (0.03, 0.33) 0.18 (0.02, 0.34) 
MiBP 0.11 (0.05, 0.18) 0.26 (0.19, 0.32) − 0.26 (− 0.97, 0.44) 0.37 (− 0.44, 1.17) 0.10 (− 0.06, 0.26) 0.14 (− 0.05, 0.33) 
MnBP 0.10 (0.04, 0.16) 0.25 (0.19, 0.32) − 0.15 (− 0.84, 0.53) 0.60 (− 0.20, 1.39) 0.12 (− 0.04, 0.28) 0.17 (− 0.01, 0.36) 
MBzP 0.31 (0.18, 0.44) 0.43 (0.31, 0.56) 0.22 (− 1.24, 1.68) 1.32 (− 0.19, 2.83) 0.32 (− 0.02, 0.65) 0.30 (− 0.06, 0.65) 
MEHP − 0.39 (− 0.50, − 0.27) − 0.33 (− 0.45, − 0.20) − 0.08 (− 1.41, 1.25) 0.55 (− 0.85, 1.95) − 0.16 (− 0.46, 0.15) − 0.12 (− 0.45, 0.21) 
MECPP − 0.05 (− 0.16, 0.06) 0.02 (− 0.09, 0.13) − 0.15 (− 1.28, 0.97) 0.43 (− 0.73, 1.60) 0.01 (− 0.25, 0.27) 0.06 (− 0.22, 0.33) 
MCMHP − 0.04 (− 0.14, 0.06) 0.00 (− 0.10, 0.11) − 0.50 (− 1.57, 0.57) − 0.07 (− 1.15, 1.01) 0.00 (− 0.24, 0.25) 0.03 (− 0.23, 0.29) 
MiNP − 0.28 (− 0.41, − 0.16) − 0.22 (− 0.35, − 0.09) − 0.38 (− 1.73, 0.97) 0.49 (− 0.93, 1.91) − 0.30 (− 0.61, 0.00) − 0.37 (− 0.70, − 0.03) 
MiDP 0.06 (− 0.07, 0.19) 0.17 (0.03, 0.30) 0.09 (− 1.29, 1.46) 1.09 (− 0.33, 2.51) 0.16 (− 0.01, 0.02) 0.14 (− 0.20, 0.48) 
Phthalate metabolite sumd 0.01 (− 0.01, 0.04) 0.06 (0.03, 0.09) − 0.01 (− 0.28, 0.27) 0.39 (0.07, 0.71) 0.02 (− 0.05, 0.08) 0.02 (− 0.06, 0.10) 
Abbreviations: TT3, total triiodothyronine; FT4, free thyroxine; TSH, thyroid stimulating hormone; CI, confidence interval. 
a Multivariable linear regression model adjusted for age and sex. 
b Multivariable linear regression model adjusted for age, sex, body mass index, residence area, tobacco use, alcohol consumption, attained education and estradiol 
levels. 
c Metabolites are log-transformed. 
d The phthalate metabolite sum is the sum of orders of all metabolites (each metabolite was categorized in tertiles and the category number of each compound was 
summed). 
Fig. 3. Associations between serum phthalate metabolites and thyroid hormone levels. Multivariable linear regression models displaying mean differences (β) 
between 3rd and 1st tertiles of phthalate metabolites (ng/mL). 
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thyroid function in adult population have been conducted. Moreover, 
the metabolites associated and the direction of associations diverge 
among these studies (Wang et al., 2018; Przybyla et al., 2018; Park et al., 
2017; Meeker and Ferguson, 2011; Meeker et al., 2007; Huang et al., 
2017). Nevertheless, specifically DEHP and its metabolites – which have 
been analyzed in most of these studies conducted in different adult 
populations – have consistently linked to lowered total T3 and total or 
free T4 levels and increased TSH levels (Kim et al., 2019; Park et al., 
2017; Meeker and Ferguson, 2011; Meeker et al., 2007; Huang et al., 
2017). Our findings are somewhat consistent with this preceding evi-
dence. We found a dose-dependent inverse association of MEHP with 
TT3 levels, although not with FT4 or TSH levels. The other DEHP’s 
metabolites, i.e. MECPP and MCMHP, were present in much lower 
serum concentration than MEHP and no associations were evidenced 
with any thyroid hormone. 
In relation to phthalates other than DEHP, even less has been studied; 
but when assessed, generally they were inversely associated with thy-
roid hormone levels (Wang et al., 2018; Przybyla et al., 2018; Park et al., 
2017). The exception was a population-based study conducted with 279 
Taiwanese adults, where urinary DEHP’s metabolites were negatively 
associated with FT4 levels but MEP was positively associated (Huang 
et al., 2017), in line with our results. In the present study in GraMo 
cohort, LMW phthalates, including MEP but also MMP, MiBP, MnBP and 
MBzP, were significantly associated with higher levels of total TT3 
levels. LMW phthalates have been poorly investigated in relation to 
thyroid hormone disruption. 
Several factors could explain the discrepancy between our findings 
and previous studies, such as the phthalate exposure differences be-
tween countries and over time, the control for covariates that could bias 
the associations, the different biological matrix in which phthalates 
exposure was assessed or even genetic variations modulating the sus-
ceptibility of individuals to phthalates toxicity (Johns et al., 2015a). 
Following exposure, phthalates are rapidly metabolized and excreted 
in urine and feces. Thus, because phthalates have relatively short half- 
lives (Calafat et al., 2015; Johns et al., 2015b), serum concentrations 
of phthalate metabolites may be substantially lower than in urine 
(Frederiksen et al., 2010; Koch et al., 2005; Silva et al., 2003). Also, 
urinary metabolite concentrations have reduced potential for contami-
nation by the parent diester and subsequent formation of metabolites by 
enzymes present in blood (Johns et al., 2015a; Calafat et al., 2015; Koch 
and Calafat, 2009). Other advantages of measurement of phthalate 
metabolites in urine over in blood include ease of sample collection and 
larger sample volumes (Koch and Calafat, 2009). This justifies why 
previous studies of human phthalate exposure have largely been based 
on urinary concentrations of its metabolites (Wang et al., 2019). How-
ever, when assessing potential health effects of the exposure, serum 
phthalate concentrations may provide very valuable information since 
they lie closer to biologically effective dose. 
The distribution pattern of metabolites in serum is suggested to be 
similar to that of urine and reasonable correlations between phthalate 
metabolite concentrations in urine and in serum have been reported 
(Frederiksen et al., 2010; Hines et al., 2009; Hogberg et al., 2008; Kato 
et al., 2004). Also, in most of these biomonitoring studies, whether based 
on urine or serum, metabolites of DEHP, DEP and DBP were the major 
compounds identified (Wang et al., 2019), which is in agreement with 
our findings. Finally, although for most phthalates the monoester 
metabolite is thought to be more biologically active than the parent 
diester Centers for Disease Control and Prevention (2009), some degree 
of random measurement error due to the lack of precise measures of the 
biologically effective dose at the target tissue for the entire duration of 
the relevant exposure cannot be ruled out. Thus, the measurement of 
metabolite concentrations in serum (and in urine) could serve as a valid 
approach to estimating exposure to phthalates (Henriksen et al., 2020), 
although careful consideration of the limitations of this approach is 
required when interpreting study results. 
A general limitation in the epidemiological field is the cross-sectional 
Table 3 
Association between serum phthalate tertiles and prevalence of potential sub-
clinical hyperthyroidism (TT3 y/o FT4 above the range considered normal).  
Phthalate metabolites c Cases N Prevalence of potential subclinical 
hyperthyroidism 
Model 1 Model 2 
OR (95% CI)a OR (95% CI)b 
MMP     
1st Tertile 20 95 Ref. Ref. 
2nd Tertile 22 56 2.62 (1.25, 5.53) 2.03 (0.80, 5.11) 
3rd Tertile 22 56 2.58 (1.22, 5.44) 2.41 (1.01, 5.73) 
As continuous (ng/mL)   1.30 (1.08, 1.57) 1.24 (1.00, 1.55) 
MEPy
1st Tertile 20 69 Ref. Ref. 
2nd Tertile 22 69 1.13 (0.54, 2.35) 1.65 (0.73, 3.73) 
3rd Tertile 22 69 1.18 (0.56, 2.46) 1.85 (0.80, 4.32) 
Cont.   1.07 (0.88, 1.30) 1.19 (0.95, 1.48) 
MiBP     
T1 20 54 Ref. Ref. 
T2 25 77 0.82 (0.39, 1.71) 1.38 (0.60, 3.20) 
T3 19 76 0.52 (0.24, 1.12) 1.12 (0.41, 3.06) 
Cont.   0.89 (0.72, 1.10) 1.09 (0.84, 1.40) 
MnBP     
T1 13 42 Ref. Ref. 
T2 27 83 1.04 (0.46, 2.35) 2.19 (0.83, 5.74) 
T3 24 82 0.83 (0.36, 1.90) 2.35 (0.80, 6.89) 
Cont.   0.96 (0.79, 1.18) 1.23 (0.95, 1.59) 
MBzP§     
< LOD 48 155 Ref. Ref. 
≥ LOD 16 52 0.99 (0.50, 1.98) 1.57 (0.71, 3.47) 
Cont.   1.13 (0.75, 1.71) 1.46 (0.91, 2.35) 
MEHPy
T1 27 69 Ref. Ref. 
T2 16 69 0.45 (0.21, 0.96) 0.58 (0.26, 1.30) 
T3 21 69 0.68 (0.33, 1.38) 0.97 (0.43, 2.18) 
Cont.   0.74 (0.50, 1.11) 0.89 (0.57, 1.40) 
MECPP     
T1 8 22 Ref. Ref. 
T2 31 93 0.92 (0.34, 2.45) 1.13 (0.39, 3.30) 
T3 25 92 0.68 (0.25, 1.84) 0.94 (0.31, 2.84) 
Cont.   0.72 (0.52, 1.01) 0.79 (0.55, 1.13) 
MCMHP     
T1 18 40 Ref. Ref. 
T2 26 84 0.54 (0.24, 1.19) 0.72 (0.30, 1.75) 
T3 20 83 0.41 (0.18, 0.92) 0.50 (0.20, 1.23) 
Cont.   0.71 (0.51, 0.99) 0.75 (0.53, 1.06) 
MiNP     
T1 14 35 Ref. Ref. 
T2 26 86 0.65 (0.28, 1.49) 0.92 (0.37, 2.27) 
T3 24 86 0.59 (0.26, 1.37) 0.87 (0.34, 2.20) 
Cont.   0.77 (0.52, 1,15) 0.89 (0.57, 1.38) 
MiDP     
T1 27 98 Ref. Ref. 
T2 19 55 1.34 (0.65, 2.76) 1.76 (0.80, 3.85) 
T3 18 54 1.24 (0.60,.2.56) 2.36 (1.01, 5.50) 
Cont.   0.96 (0.65, 1.44) 1.30 (0.83, 2.06) 
Phthalate sum     
T1 48 72 Ref. Ref. 
T2 21 75 0.76 (0.37, 1.54) 1.49 (0.63, 3.51) 
T3 19 60 0.93 (0.44, 1.94) 2.15 (0.84, 5.50) 
Cont.   0.98 (0.90, 1.06) 1.08 (0.97, 1.19) 
4 The phthalate metabolite sum is the sum of orders of all metabolites (each 
metabolite was categorized in tertiles and the category number of each com-
pound was summed). 
Abbreviations: TT3, total triiodothyronine; FT4, free thyroxine; TSH, thyroid 
stimulating hormone; CI, confidence interval. 
a Multivariable linear regression model adjusted for age and sex. 
b Multivariable linear regression model adjusted for age, sex, body mass index, 
residence area, tobacco use, alcohol consumption and attained education. 
c Metabolites are log-transformed. The first tertile comprises those subjects 
with phthalate levels < LOD except for MEP and MEHP (<8% observations <
LOD) which have been categorized into tertiles by the usual procedure after 
imputing the LOD/square root of 2 to those with levels < LOD). For MBzP (>70 
%observations < LOD) and was dichotomized in <LOD and ≥LOD. 
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nature of most studies, including the current work, which limits causal 
inference. However, it is highly unlikely – and there is not a known 
mechanism – that simultaneity or reverse causality occur in the thyroid 
hormone levels-phthalate metabolites relationship. No residual confu-
sion can be guaranteed. Also, in our study, only a single serum sample 
per participant was used. Because phthalates are nonpersistent chem-
icals with short half-lives, detected phthalates in a single sample rather 
than reflecting a person’s usual exposure over months to years, could 
reflect recent specific exposure. 
WQS regression have become widely used to estimate the joint effect 
of all exposures in a mixture. One important limitation of WQS regres-
sion, however, is that the joint effects of chemicals with diverse effect 
directions cannot be assessed simultaneously. Also, it estimates the 
combined effect of these exposures under the assumption that associa-
tions are linear and additive and potential synergistic effects cannot be 
addressed (Zhang et al., 2019). Other different methodologies than WQS 
regression have recently developed to analyze the effects of chemical 
mixtures on health, such as the Bayesian kernel machine regression 
(Bobb et al., 2015) or the newest and promising method Quantile 
g-Computation (Schmidt, 2020). However, for the current data, we 
considered that the most suitable approach was probably the WQS 
regression. The WQS regression examines the joint action of the chem-
ical exposures based on the weights empirically determined by bootstrap 
sampling. WQS regression performs well in characterizing chemicals of 
concern under multiple environmentally relevant simulation studies 
(Carrico et al., 2015; Hargarten and Wheeler, 2020; Bello, 2014). WQS 
Fig. 4. Estimation of the mixture effect of phthalate metabolites on total triiodothyronine (A) and free thyroxine (B) levels. Weighted quantile sum regression 
(WQS) analyses. 
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analyses are increasingly being performed in environmental epidemi-
ology (Artacho-Cordon et al., 2019; Arrebola et al., 2019; Marks et al., 
2021; Loftus et al., 2021; Wu et al., 2020). The advantages and limita-
tions of this approach have been recently discussed elsewhere (Zhang 
et al., 2019; Gibson et al., 2019). 
Although acid was added to serum samples immediately after 
centrifugation to inhibit enzyme activity, we cannot rule out that some 
conversion of diesters from sample contamination happens within the 
short period between drawing of blood, centrifugation, and final ali-
quoting (Calafat et al., 2015). While thyroid hormones were also 
assessed in one serum sample, human levels seems to be vary within 
relatively narrow limits over time (Andersen et al., 2002) and using of 
point measurements would yield to a non-differential error (random 
misclassification), that would bias measures of association toward the 
null value. The sample size available for these analyzes was limited and 
could compromise the statistical power in some analysis. 
Importantly, despite we recruited a variety of individuals covering 
wide age, obesity and education ranges, our hospital-based cohort may 
not be entirely representative of the general population. However, levels 
of both serum phthalates and thyroid hormones are likely unrelated to 
the selection criteria (patients undergoing non-cancer-related surgery 
and free of any hormonal disease related to hypothalamic axis). In 
addition, we included a wide diversity of conditions, e.g., hernias in 
different locations, gallbladder disease, and varicose veins, among 
others. This might potentially represent a non-differential error and 
attenuate the associations; however, it is not likely to produce false 
positive associations. Therefore, we believe that the associations found 
in GraMo are relevant, deserve attention from the scientific community, 
and might be reproduced in the general population. 
Regarding the biomarker selection, we acknowledge that urine 
concentrations might be more representative of the total phthalate 
exposure since these chemicals are more easily detected in urine. 
However, we used serum samples on the bases that they are closer to the 
biologically effective dose. Despite the mentioned limitations of serum 
phthalate concentrations, moderate to strong correlations have 
frequently been found (Frederiksen et al., 2010; Hines et al., 2009; 
Hogberg et al., 2008; Kato et al., 2004). Indeed, a review article 
concluded that despite these correlations might not always exist at an 
individual level, they can be relevant at a population level, in which 
people are continuously exposed to these chemicals (Johns et al., 
2015b). Therefore, differences in serum vs urine would mainly affect 
exposure assessment to those metabolites found at lower concentrations. 
As the main strength stands out the large number of phthalate me-
tabolites assessed and consistency throughout the different approaches 
used. Likewise, phthalate metabolites in serum may be a better indicator 
of the biologically effective dose than other biomarker measurements, 
which can be indicators of phthalate internal dose but not necessarily 
the bioactive one. 
This study represents a unique opportunity to assess potential early 
(sub)clinical damages in thyroid function in relation to the ubiquitous 
phthalate exposure in adult population. Early-life exposure to phthalates 
and other endocrine disrupting chemicals has been considered a major 
concern, meanwhile, exposures during non-developmental periods have 
not gained as much attention. Although there is no question that the 
developmental stage constitutes the most susceptible period to toxicity 
of environmental chemicals, the reality is that human exposure is 
continuous from conception to death. An integrated approach of further 
high-quality epidemiological studies including phthalate exposure over 
lifetime is warranted to provide a stronger basis for regulatory decisions. 
5. Conclusions 
Our results suggest that phthalate metabolites associate with serum 
levels of TT3 and FT4 in both sexes. The overall phthalate metabolite 
concentrations were related to higher serum TT3 and FT4 levels, slightly 
more pronounced in women. We also evidenced that phthalate 
metabolites with different molecular weight may be associated in the 
opposite way with thyroid hormones. Our study provides potentially 
relevant results for public health that warrant confirmation in further 
prospective epidemiological studies with larger sample size and using 
repeated measurements. 
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